Sight Sciences (SGHT) Amortization of Deferred Charges (2020 - 2026)
Sight Sciences' (SGHT) quarterly Amortization of Deferred Charges came in at $233000.0 in Q1 2026, up 2.19% year-on-year from $228000.0 in Q1 2025, and up 1.3% quarter-over-quarter from $230000.0 in Q4 2025.
Sight Sciences (SGHT) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
Sight Sciences' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $233000.0 for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 2.19% year-over-year to $233000.0 in Q1 2026; TTM through Mar 2026 was $949000.0, a 6.99% increase from a year earlier, with the FY2025 full-year figure at $944000.0, up 25.37% from the prior year.
- Amortization of Deferred Charges grew to $233000.0 in Q1 2026 per SGHT's latest filing, from $230000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $382000.0 in Q3 2024 and bottomed at $74000.0 in Q2 2024.
- The 5-year median for Amortization of Deferred Charges is $167000.0 (2022), against an average of $188294.1.
- Across the five-year window, Amortization of Deferred Charges plunged 50.67% in 2024 and jumped 220.27% in 2025, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $155000.0 in 2022, then advanced by 4.52% to $162000.0 in 2023, then grew by 25.31% to $203000.0 in 2024, then grew by 13.3% to $230000.0 in 2025, then grew by 1.3% to $233000.0 in 2026.
- Per Business Quant, the three latest SGHT Amortization of Deferred Charges figures stand at $233000.0 (Q1 2026), $230000.0 (Q4 2025), and $249000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Sight Sciences | 276.19 Mn | 191.23 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 233,000.00 |
| Mar 31, 2026 | 233,000.00 |
| Dec 31, 2025 | 230,000.00 |
| Dec 31, 2025 | 230,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Sep 30, 2025 | 249,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | 228,000.00 |
| Mar 31, 2025 | 228,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Dec 31, 2024 | 203,000.00 |
| Sep 30, 2024 | 382,000.00 |
| Sep 30, 2024 | 382,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 94,000.00 |
| Mar 31, 2024 | 94,000.00 |
| Dec 31, 2023 | 162,000.00 |
| Dec 31, 2023 | 162,000.00 |